Moors & Cabot’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.79M Buy
+7,013
New +$1.73M 0.07% 257
2017
Q3
– Sell
-12,675
Closed -$244K – 552
2017
Q2
$244K Sell
12,675
-825
-6% -$14.4K 0.04% 423
2017
Q1
$242K Buy
+13,500
New +$250K 0.04% 419
2015
Q1
– Sell
-4,187
Closed -$213K – 541
2014
Q4
$213K Sell
4,187
-200
-5% -$10.5K 0.04% 438
2014
Q3
$262K Sell
4,387
-112
-2% -$6.25K 0.04% 411
2014
Q2
$211K Buy
+4,499
New +$203K 0.04% 470

Other funds holding THC

Moors & Cabot's THC Position: Q3 2026 in Review

Moors & Cabot opened a new position in Tenet Healthcare (THC) in Q3 2026: 7,013 shares worth $1.79M. The stake represents 0.07% of the portfolio and ranks #257 among its holdings. This is a return to the name: Moors & Cabot previously reported a position in THC as recently as Q2 2017.

Moors & Cabot first reported a position in THC in Q2 2014 and has held it in 6 quarters since. 366 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Moors & Cabot held 7,013 shares of Tenet Healthcare worth $1.79M as of Q3 2026.
  • Tenet Healthcare was a new Moors & Cabot position in Q3 2026.
  • Tenet Healthcare made up 0.07% of Moors & Cabot's portfolio in Q3 2026, its #257 holding.
  • Moors & Cabot first reported a position in Tenet Healthcare in Q2 2014 and has held it in 6 quarters since.
  • 366 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Moors & Cabot's 13F filing for Q3 2026, filed 6 Nov 2026.